Public Lecture: 'Why Nanomedicine is NANO?' Held
On September 29, we hosted the first public lecture of the FY2024 iCONM/CHANGE series titled 'Why Nanomedicine is NANO? – Considering Mesh Sizes within the Body,' which was held online.
The lecture began with an overview of nanomedicine by Kazunori Kataoka, Center Director of iCONM, who explained the size effects in nanomedicine. Following this, Kanjiro Miyata (Professor at the University of Tokyo Graduate School of Engineering) discussed the measurement of biological gaps using 'nano rulers' and the precise drug delivery techniques that utilize the varying size effects across different tissues. Additionally, Ichio Aoki, Senior Principal Investigator at the National Institute for Quantum and Radiological Science and Technology, spoke about the future of medicine brought about by nanotechnology and MRI.
During the Q&A session, there was a lively discussion on clinical research related to the applications of nanomedicine and the future challenges it faces. A total of 85 participants attended the event. Feedback from participants included positive comments such as, 'The complex topics were explained in an easy-to-understand manner' and 'I felt closer to cutting-edge medicine,' indicating a strong resonance with the research being conducted at iCONM/CHANGE.
